52nd Congress of the Italian Society of Neurology
Highlights of the scientific event's press conference
52nd Congress of the Italian Society of Neurology
Highlights of the scientific event's press conference
Press conference that exemplifies the atmosphere and expectations of important changes that can be found in the neurological research and clinical sectors. From the hopes aroused by recent studies on the treatments of Alzheimer's and other neurodegenerative diseases to the expectations regarding the development of the uses of Artificial Intelligence in numerous fields of neurology, there are numerous stimulating topics proposed by the SIN speakers.
Press conference that exemplifies the atmosphere and expectations of important changes that can be found in the neurological research and clinical sectors. From the hopes aroused by recent studies on the treatments of Alzheimer's and other neurodegenerative diseases to the expectations regarding the development of the uses of Artificial Intelligence in numerous fields of neurology, there are numerous stimulating topics proposed by the SIN speakers.
Alpha-synuclein dosage methods in the various forms of Parkinson's
it
Prof. Alfredo Berardelli
Alzheimer, which clinical and organizational perspectives for the new monoclonals
it
Prof. Alessandro Padovani
Possible applications of AI in management of neurological diseases
it
Prof. Stefano F. Cappa
Neurological complications from Covid-19: incidence and sequelae
it
Prof. Carlo Ferrarese
MS: many therapies available today. The challenge is to customize treatments
it
Prof. Massimo Filippi
Sleep quality and neurodegenerative diseases
it
Prof. Giuseppe Plazzi
Neuromuscular diseases: a rapidly evolving therapeutic landscape
it
Prof. Antonio Toscano
ALS management, valuable support from AI and Machine Learning
it
Prof. Vincenzo Silani
Identifying patients with preclinical forms of Alzheimer's
it
Prof. Camillo Marra
Migraine: the evolution of anti-CGRP monoclonal antibodies
it
Prof. Antonio Russo